Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on May 12, 2005

Arteriosclerosis, Thrombosis, and Vascular Biology. 2005
Published online before print May 12, 2005, doi: 10.1161/01.ATV.0000170137.41079.ab
A more recent version of this article appeared on August 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/8/1596    most recent
01.ATV.0000170137.41079.abv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, J. L.
Right arrow Articles by Brosius III, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, J. L.
Right arrow Articles by Brosius III, F. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
*PROSTAGLANDIN F2ALPHA
Medline Plus Health Information
*High Blood Pressure

Submitted on August 31, 2004
Accepted on May 2, 2005

GLUT4 Facilitative Glucose Transporter Specifically and Differentially Contributes to Agonist-Induced Vascular Reactivity in Mouse Aorta

James L. Park ; Robert D. Loberg ; Damon Duquaine ; Hongyu Zhang ; Baljit K. Deo ; Noelia Ardanaz ; Jami Coyle ; Kevin B. Atkins ; MaryLee Schin ; Maureen J. Charron ; Arno K. Kumagai ; Patrick J. Pagano ; and Frank C. Brosius III *

From the Departments of Internal Medicine (J.L.P., R.D.L., D.D., H.Z., B.KD., J.C., K.B.A., M.S., A.K.K., F.C.B.) and Physiology (R.D.L., F.C.B.), University of Michigan Medical School, Ann Arbor, Mich; the Department of Biochemistry (M.J.C.), Albert Einstein College of Medicine; and the Hypertension and Vascular Research Division (N.A., P.J.P.), Henry Ford Hospital.

* To whom correspondence should be addressed. E-mail: fbrosius{at}umich.edu.

Objective--We hypothesized that GLUT4 is a predominant facilitative glucose transporter in vascular smooth muscle cells (VSMCs), and GLUT4 is necessary for agonist-induced VSMC contraction.

Methods and Results--Glucose deprivation and indinavir, a GLUT4 antagonist, were used to assess the role of GLUT4 and non-GLUT4 transporters in vascular reactivity. In isolated endothelium-denuded mouse aorta, {approx}50% of basal glucose uptake was GLUT4-dependent. Norepinephrine-mediated contractions were dependent on both GLUT4 and non-GLUT4 transporters, serotonin (5-HT)-mediated contractions were mainly GLUT4-dependent, and prostaglandin (PG) F2{alpha}-mediated contractions were dependent on non-GLUT4 transporters, whereas indinavir had no effect in GLUT4 knockout vessels. We also observed a 46% decrease in GLUT4 expression in aortas from angiotensin II hypertensive mice. Indinavir caused a less profound attenuation of maximal 5-HT-mediated contraction in these vessels, corresponding to the lower GLUT4 levels in the hypertensive aortas. Finally, and somewhat surprisingly, chronic GLUT4 knockout was associated with increased vascular reactivity compared with that in wild-type animals, suggesting that chronic absence or reduction of GLUT4 expression in VSMCs leads to opposite effects observed with acute inhibition of GLUT4.

Conclusions--Thus, we conclude that GLUT4 is constitutively expressed in large arteries and likely participates in basal glucose uptake. In addition, GLUT4, as well as other non-GLUT4 facilitative glucose transporters, are necessary for agonist-induced contraction, but each transporter participates in VSMC contraction selectively, depending on the agonist, and changes in GLUT4 expression may account for some of the functional changes associated with vascular diseases like hypertension.


Key words: glucose • GLUT4 • indinavir • vascular smooth muscle




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
P. R. Nagareddy, F. L. Chow, L. Hao, X. Wang, T. Nishimura, K. M. MacLeod, J. H. McNeill, and C. Fernandez-Patron
Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis
Cardiovasc Res, December 1, 2009; 84(3): 368 - 377.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. B. Atkins, A. Prezkop, J. L. Park, J. Saha, D. Duquaine, M. J. Charron, A. L. Olson, and F. C. Brosius 3rd
Preserved expression of GLUT4 prevents enhanced agonist-induced vascular reactivity and MYPT1 phosphorylation in hypertensive mouse aorta
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H402 - H408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. H. Schulman, M.-S. Zhou, E. A. Jaimes, and L. Raij
Dissociation between metabolic and vascular insulin resistance in aging
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H853 - H859.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. J. Miller, J. Li, K. M. Sinusas, G. D. Holman, and L. H. Young
Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heart
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1922 - E1928.
[Abstract] [Full Text] [PDF]